Paradigm Biocapital Advisors’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-659,724	Closed	-$3.83M	–	32
2024 Q2	$3.83M	Buy	+659,724	New	+$3.83M	0.15%	34